 | • レポートコード：D0804-16544 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、104ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、呼吸器合胞体ウイルス（RSV）診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。呼吸器合胞体ウイルス（RSV）診断の種類別市場規模（分子診断、抗原迅速検査、その他）、用途別市場規模（病院、クリニック、研究室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Gilead Sciences、AbbVie、AstraZeneca、ReViral、Merck、GlaxoSmithKline、Bausch Health、Teva Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・呼吸器合胞体ウイルス（RSV）診断の北米市場（アメリカ、カナダ、メキシコ） ・呼吸器合胞体ウイルス（RSV）診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・呼吸器合胞体ウイルス（RSV）診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・呼吸器合胞体ウイルス（RSV）診断の南米市場（ブラジル、アルゼンチン） ・呼吸器合胞体ウイルス（RSV）診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：分子診断、抗原迅速検査、その他 ・用途別分析：病院、クリニック、研究室、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Respiratory Syncytial Virus (RSV) Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Respiratory Syncytial Virus (RSV) Diagnostics sales will be xx in 2020 from Respiratory Syncytial Virus (RSV) Diagnostics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Respiratory Syncytial Virus (RSV) Diagnostics market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Respiratory Syncytial Virus (RSV) Diagnostics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Respiratory Syncytial Virus (RSV) Diagnostics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Respiratory Syncytial Virus (RSV) Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Respiratory Syncytial Virus (RSV) Diagnostics market has been segmented into:
Molecular Diagnosis
Rapid Antigen Testing
Other
By Application, Respiratory Syncytial Virus (RSV) Diagnostics has been segmented into:
Hospital
Clinic
Laborary
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Respiratory Syncytial Virus (RSV) Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Respiratory Syncytial Virus (RSV) Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Respiratory Syncytial Virus (RSV) Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Respiratory Syncytial Virus (RSV) Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Respiratory Syncytial Virus (RSV) Diagnostics Market Share Analysis
Respiratory Syncytial Virus (RSV) Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Respiratory Syncytial Virus (RSV) Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Respiratory Syncytial Virus (RSV) Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Respiratory Syncytial Virus (RSV) Diagnostics are:
Roche
Gilead Sciences
AbbVie
AstraZeneca
ReViral
Merck
GlaxoSmithKline
Bausch Health
Teva Pharmaceutical
Among other players domestic and global, Respiratory Syncytial Virus (RSV) Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
1.1 Product Overview and Scope of Respiratory Syncytial Virus (RSV) Diagnostics
1.2 Classification of Respiratory Syncytial Virus (RSV) Diagnostics by Type
1.2.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Type in 2019
1.2.3 Molecular Diagnosis
1.2.4 Rapid Antigen Testing
1.2.5 Other
1.3 Global Respiratory Syncytial Virus (RSV) Diagnostics Market by Application
1.3.1 Overview: Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laborary
1.3.5 Other
1.4 Global Respiratory Syncytial Virus (RSV) Diagnostics Market by Regions
1.4.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Respiratory Syncytial Virus (RSV) Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Respiratory Syncytial Virus (RSV) Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Respiratory Syncytial Virus (RSV) Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Respiratory Syncytial Virus (RSV) Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Respiratory Syncytial Virus (RSV) Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Respiratory Syncytial Virus (RSV) Diagnostics Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Respiratory Syncytial Virus (RSV) Diagnostics Industry Impact
1.5.1 COVID-19 Potential Implications for the Respiratory Syncytial Virus (RSV) Diagnostics
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Respiratory Syncytial Virus (RSV) Diagnostics
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gilead Sciences SWOT Analysis
2.2.4 Gilead Sciences Product and Services
2.2.5 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AbbVie SWOT Analysis
2.3.4 AbbVie Product and Services
2.3.5 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 ReViral
2.5.1 ReViral Details
2.5.2 ReViral Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ReViral SWOT Analysis
2.5.4 ReViral Product and Services
2.5.5 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck Product and Services
2.6.4 Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GlaxoSmithKline Product and Services
2.7.4 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bausch Health
2.8.1 Bausch Health Details
2.8.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bausch Health Product and Services
2.8.4 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceutical Product and Services
2.9.4 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Respiratory Syncytial Virus (RSV) Diagnostics Players Market Share
3.2.2 Top 10 Respiratory Syncytial Virus (RSV) Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Market Share by Regions
4.2 North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries
5.1 North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries (2015-2020)
5.2 USA Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries
6.1 Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries
7.1 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries (2015-2020)
7.2 China Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries
8.1 South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Respiratory Syncytial Virus (RSV) Diagnostics by Countries
9.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Forecast by Type (2019-2024)
10.3 Molecular Diagnosis Revenue Growth Rate (2015-2025)
10.4 Rapid Antigen Testing Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segment by Application
11.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Respiratory Syncytial Virus (RSV) Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Laborary Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Forecast (2021-2025)
12.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Forecast (2021-2025)
12.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Respiratory Syncytial Virus (RSV) Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Roche Corporate Information, Location and Competitors
Table 7. Roche Respiratory Syncytial Virus (RSV) Diagnostics Major Business
Table 8. Roche Respiratory Syncytial Virus (RSV) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 9. Roche SWOT Analysis
Table 10. Roche Respiratory Syncytial Virus (RSV) Diagnostics Product and Solutions
Table 11. Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Gilead Sciences Corporate Information, Location and Competitors
Table 13. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Major Business
Table 14. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Total Revenue (USD Million) (2018-2019)
Table 15. Gilead Sciences SWOT Analysis
Table 16. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Product and Solutions
Table 17. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. AbbVie Corporate Information, Location and Competitors
Table 19. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Major Business
Table 20. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 21. AbbVie SWOT Analysis
Table 22. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Product and Solutions
Table 23. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. AstraZeneca Corporate Information, Location and Competitors
Table 25. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Major Business
Table 26. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 27. AstraZeneca SWOT Analysis
Table 28. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Product and Solutions
Table 29. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. ReViral Corporate Information, Location and Competitors
Table 31. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Major Business
Table 32. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 33. ReViral SWOT Analysis
Table 34. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Product and Solutions
Table 35. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Merck Corporate Information, Location and Competitors
Table 37. Merck Respiratory Syncytial Virus (RSV) Diagnostics Major Business
Table 38. Merck Respiratory Syncytial Virus (RSV) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 39. Merck SWOT Analysis
Table 40. Merck Respiratory Syncytial Virus (RSV) Diagnostics Product and Solutions
Table 41. Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. GlaxoSmithKline Corporate Information, Location and Competitors
Table 43. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Major Business
Table 44. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 45. GlaxoSmithKline SWOT Analysis
Table 46. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Product and Solutions
Table 47. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Bausch Health Corporate Information, Location and Competitors
Table 49. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Major Business
Table 50. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 51. Bausch Health SWOT Analysis
Table 52. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Product and Solutions
Table 53. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 55. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Major Business
Table 56. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Total Revenue (USD Million) (2017-2018)
Table 57. Teva Pharmaceutical SWOT Analysis
Table 58. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Product and Solutions
Table 59. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 61. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Players (2015-2020)
Table 62. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Regions (2015-2020)
Table 64. North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries (2015-2020)
Table 65. North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries (2015-2020)
Table 66. Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Countries (2015-2020)
Table 69. South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries (2015-2020)
Table 72. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 73. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Type (2015-2020)
Table 74. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Forecast by Type (2021-2025)
Table 75. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Application (2015-2020)
Table 76. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Application (2015-2020)
Table 77. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Forecast by Application (2021-2025)
Table 78. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Respiratory Syncytial Virus (RSV) Diagnostics Picture
Figure 2. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Type in 2019
Figure 3. Molecular Diagnosis Picture
Figure 4. Rapid Antigen Testing Picture
Figure 5. Other Picture
Figure 6. Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Laborary Picture
Figure 10. Other Picture
Figure 11. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Regions in 2018
Figure 25. North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries in 2019
Figure 32. USA Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries in 2019
Figure 37. Germany Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. UK Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. France Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries in 2019
Figure 44. China Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. India Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries in 2019
Figure 51. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Type (2015-2020)
Figure 60. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Type in 2019
Figure 61. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share Forecast by Type (2021-2025)
Figure 62. Global Molecular Diagnosis Revenue Growth Rate (2015-2020)
Figure 63. Global Rapid Antigen Testing Revenue Growth Rate (2015-2020)
Figure 64. Global Other Revenue Growth Rate (2015-2020)
Figure 65. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Application (2015-2020)
Figure 66. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Share by Application in 2019
Figure 67. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospital Revenue Growth Rate (2015-2020)
Figure 69. Global Clinic Revenue Growth Rate (2015-2020)
Figure 70. Global Laborary Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. Europe Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. South America Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
ウイルス検査診断キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Virus Testing Diagnostic Kits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Virus Testing D…- 呼吸器疾患検査の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Respiratory Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory Disea…
- ウイルスリアルタイムPCR検出キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Virus Real Time PCR Detection Kit market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Virus Real …
- 呼吸器用医療装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Respiratory Medical Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory Medica…
- 呼吸器用監視機器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Respiratory Monitoring Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…